A systematic review of cost-effectiveness analyses on endovascular thrombectomy in ischemic stroke patients.

Xiao WuMihir KhunteDheeraj GandhiPina SanelliHoward P FormanJoseph Schindler

Published in: European radiology (2022)

• All included studies concluded thrombectomy to be cost-effective, from both long- and short-term perspectives. • Only 5 out of 22 studies undertook a societal perspective, and only 1 accounted for indirect costs. • The range of value for mRS 0-2 was 0.71-0.85 quality-adjusted life year (QALY) and 0.21-0.40 QALY for mRS 3-5.

Keyphrases

end stage renal disease
acute ischemic stroke
newly diagnosed
ejection fraction
chronic kidney disease
case control
peritoneal dialysis
prognostic factors
atrial fibrillation
patient reported outcomes
quality improvement